Skip to content
Search

Latest Stories

End of the road for free provision of Covid tests?

A news report suggests the Department of Health and Social Care is aiming to be ready to start charging for Covid tests which are currently free at the end of June.

Britain has been increasingly dependent on rapid testing to try to tackle the more-transmissible Omicron variant, which has spread rapidly through the population but is less severe.


The government has previously said it will end the universal free provision of easy-to-use lateral flow devices (LFDs) at a "later stage", with individuals and businesses bearing the cost.

The Department of Health has declined to say what the tests cost, citing commercial contracts. One source has told the Reuters news agency they can run to £30 for a pack of seven.

Free pick up from pharmacies

The tests have been made freely available to order online or pick up from local pharmacies since April. The UK Health Security Agency said that between December 30 and January 5 more than 8 million LFDs were conducted, the highest weekly figure on record.

The document seen by Reuters, which was shared between health agencies to prepare scenarios for the change, shows that the timetable for the switch has been pushed back from earlier in the year because of the arrival of the Omicron variant.

That target could move again if the virus throws what one official close to the health service described as a "curve ball", perhaps in the form of another variant, which would mean the plans would again be postponed.

The document says officials are now working on the premise that an online ordering system should be ready at the end of June to direct most people, excluding key workers and some others, to providers of paid-for LFDs in what is described as a "ramp down of the Universal Testing Offer".

Free as long as necessary

"We will continue to provide free tests as long as necessary. It is one of the most important lines of defence, alongside our vaccines programme," a government spokesman said when asked about the new date.

"With cases remaining high, we continue to process millions of tests a day – more than any European country – providing a free LFD to anybody who needs one."

Earlier this month, education minister Nadhim Zahawi said he did not recognize a report in the Sunday Times of plans to end the free mass supply of LFDs.

Two sources told Reuters last year that the first plan was to have the infrastructure in place to start charging early this year, but that target was postponed when the Omicron wave hit Britain in late November.

The document said there would be a "triage" system to direct people as to whether they were eligible or not for a free LFD. It acknowledged that some of those who expected to get a free test but could no longer get one would react "negatively".

There was a possibility, the document said, that those people could try to game the system to access a free test.

Britain has seen a drop in coronavirus cases and a fall in hospital admissions from recent highs, leading some in government to hope that so-called Plan B restrictions in place could be removed before the end of the month.

Iain Buchan, who led a trial of the tests in Liverpool, said Britain's distinctive approach of making the rapid tests freely available for months, unlike many other countries, had been a success, and cautioned against introducing charges for tests.

"Viruses move quicker than free market economics," Buchan, chair in Public Health and Clinical Informatics at the University of Liverpool, told Reuters.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less